Enduring clinical remission in refractory celiac disease type II with tofacitinib: an open-label clinical study
Author(s):
Dieckman, T. (0000-0002-5222-6357); Schumann, M.; Beaumont, H.; Bontkes, H.J.; Koning, F. (0000-0002-4007-5715); Bouma, G.; Rcdii Tofacitinib Consortium C
Published
2024
Publication type
Article / Letter to editor
Date issued
2024-11-30
Language
English
Publisher
Elsevier
Is part of
Clinical Gastroenterology and Hepatology (2024), Vol. 22, no. 11, p. 2334-2336
